CHIMERIX INC. - COMMO
0,9351
07-ноября-24 14:59:42
15 мин. задержка
Акции
-0,0749
-7,42%
Сегодняшний диапазон
0,9079 - 1,0500
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Chimerix to Present at Cowen and Company 43rd Annual Health Care Conference
28 фев 2023 15:05:01 Источник Nasdaq GlobeNewswire
-
23 фев 2023 06:00:01 Источник Nasdaq GlobeNewswire
-
Chimerix to Present at 41st Annual J.P. Morgan Healthcare Conference
05 янв 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
08 дек 2022 16:00:00 Источник Nasdaq GlobeNewswire
-
Chimerix Responds to Rubric Capital Management
10 ноя 2022 15:30:00 Источник Nasdaq GlobeNewswire
-
Chimerix Reports Third Quarter 2022 Financial Results and Provides Operational Update
03 ноя 2022 06:00:02 Источник Nasdaq GlobeNewswire
-
27 окт 2022 15:30:00 Источник Nasdaq GlobeNewswire
-
Chimerix Announces Closing of TEMBEXA Sale to Emergent BioSolutions
26 сен 2022 15:05:00 Источник Nasdaq GlobeNewswire
-
Chimerix to Present at H.C. Wainwright 24th Annual Global Investment Conference
06 сен 2022 06:00:01 Источник Nasdaq GlobeNewswire
-
Chimerix Awarded BARDA Contract for TEMBEXA as Medical Countermeasure for Smallpox
29 авг 2022 09:45:00 Источник Nasdaq GlobeNewswire
-
Chimerix Reports Second Quarter 2022 Financial Results and Provides Operational Update
08 авг 2022 15:01:00 Источник Nasdaq GlobeNewswire
-
Chimerix Appoints Christopher L. Jordan as Vice President, Regulatory Affairs
08 авг 2022 06:00:00 Источник Nasdaq GlobeNewswire
-
Chimerix to Present at Wedbush PacGrow Healthcare Conference
02 авг 2022 06:00:01 Источник Nasdaq GlobeNewswire
-
01 авг 2022 15:01:00 Источник Nasdaq GlobeNewswire
-
24 июн 2022 09:06:16 Источник Nasdaq GlobeNewswire
-
Chimerix Announces $9.3 Million International TEMBEXA Procurement Agreement
23 июн 2022 08:15:16 Источник Nasdaq GlobeNewswire
-
Chimerix to Present at Jefferies Global Healthcare Conference
01 июн 2022 15:30:00 Источник Nasdaq GlobeNewswire
-
Chimerix to Present at H.C. Wainwright Global Investment Conference
17 май 2022 15:15:00 Источник Nasdaq GlobeNewswire
-
Chimerix Reports First Quarter 2022 Financial Results and Provides Operational Update
16 май 2022 06:00:01 Источник Nasdaq GlobeNewswire
-
Chimerix Announces Sale of TEMBEXA to Emergent BioSolutions for up to $337.5 Million plus Royalties
16 май 2022 05:30:00 Источник Nasdaq GlobeNewswire